Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Other Non-Current Liabilities: 2024

  • Zhengye Biotechnology Holding's Other Non-Current Liabilities was N/A to $20,325 in Q4 2024 from the same period last year, while for Dec 2024 it was $20,325, marking a year-over-year change of. This contributed to the annual value of $20,000 for FY2024, which is N/A change from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Other Non-Current Liabilities of $20,325 as of Q4 2024.
  • Zhengye Biotechnology Holding's Other Non-Current Liabilities' 5-year high stood at $20,325 during Q4 2024, with a 5-year trough of $20,325 in Q4 2024.
  • In the last 1 years, Zhengye Biotechnology Holding's Other Non-Current Liabilities had a median value of $20,325 in 2024 and averaged $20,325.